Perspective Therapeutics (CATX) Debt to Equity (2023 - 2026)
Perspective Therapeutics' Debt to Equity history spans 4 years, with the latest figure at $0.0 for Q1 2026.
- On a quarterly basis, Debt to Equity fell 20.97% to $0.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $0.0, a 20.97% decrease, with the full-year FY2025 number at $0.01, up 35.56% from a year prior.
- Debt to Equity hit $0.0 in Q1 2026 for Perspective Therapeutics, down from $0.01 in the prior quarter.
- Over the last five years, Debt to Equity for CATX hit a ceiling of $0.02 in Q4 2023 and a floor of $0.0 in Q1 2026.
- Historically, Debt to Equity has averaged $0.01 across 4 years, with a median of $0.01 in 2025.
- Biggest five-year swings in Debt to Equity: plummeted 74.92% in 2024 and later surged 35.56% in 2025.
- Tracing CATX's Debt to Equity over 4 years: stood at $0.02 in 2023, then crashed by 74.92% to $0.01 in 2024, then soared by 35.56% to $0.01 in 2025, then crashed by 40.98% to $0.0 in 2026.
- Business Quant data shows Debt to Equity for CATX at $0.0 in Q1 2026, $0.01 in Q4 2025, and $0.01 in Q3 2025.